Ingrid Herr
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications
ALDH1A3 promotes aggressive basal-like pancreatic cancer through an AP-1/RUNX2 enhancer network.
Journal: Oncogene
Published: April 16, 2025
Arp2/3 complex and β1 integrin drive an invasive front through extracellular matrix adaptation in pancreatic cancer.
Journal: International journal of cancer
Published: March 06, 2025
Baicalein disrupts TGF-β-induced EMT in pancreatic cancer by FTO-dependent m6A demethylation of ZEB1.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: October 31, 2024
Disrupting AGR2/IGF1 paracrine and reciprocal signaling for pancreatic cancer therapy.
Journal: Cell reports. Medicine
Published: June 19, 2024
ARP2/3 complex affects myofibroblast differentiation and migration in pancreatic ductal adenocarcinoma.
Journal: International journal of cancer
Published: May 23, 2024
Correction: The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer.
Journal: Cell death & disease
Published: January 29, 2024
Corrigendum: Establishment of tumor treating fields combined with mild hyperthermia as novel supporting therapy for pancreatic cancer.
Journal: Frontiers in oncology
Published: November 23, 2023
Corrigendum to: "Nanosilver inhibits the progression of pancreatic cancer by inducing a paraptosis-like mixed type of cell death" [Biomed. Pharmacother. 153 (2022) 113511].
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: November 16, 2023
Multi-Algorithm Analysis Reveals Pyroptosis-Linked Genes as Pancreatic Cancer Biomarkers.
Journal: Cancers
Published: November 01, 2023
Correction to: Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo.
Journal: British journal of cancer
Published: September 18, 2023
Last Updated: 09/26/2026